Vimarsana
Biggest News Aggregation in the World

Page 39 - Iagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iagnostics Today - Breaking & Trending Today

Scalable Software for Molecular Diagnostics Labs and Developers - Vimarsana News

Scalable Software for Molecular Diagnostics Labs and Developers

Thermo Fisher Scientific has unveiled Diomni Enterprise Software, a powerful solution designed to streamline and standardise routine diagnostics testing, enabling faster time-to-results and improved collaboration within molecular diagnostics labs. Click to read more...

Fungal infections: A rare but important cause of chronic sinusitis - Vimarsana News

Fungal infections: A rare but important cause of chronic sinusitis

A new research perspective was published in Oncoscience (Volume 10) on May 27, 2023, entitled, "Think outside the box – atypical infections in chronic sinusitis."

Quanterix launches LucentAD Biomarker blood test to aid physician diagnosis of Alzheimer's disease in patients - Vimarsana News

Quanterix launches LucentAD Biomarker blood test to aid physician diagnosis of Alzheimer's disease in patients

Quanterix Corporation, a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced it has launched LucentAD, a test to assist in the evaluation of patients experiencing cognitive symptoms consistent with the early signs of Alzheimer’s disease (AD).

Europe Imposes Maximum Fine on Illumina for Early Grail Acquisition - Vimarsana News

Europe Imposes Maximum Fine on Illumina for Early Grail Acquisition

Illumina must pay a €432 million fine for closing its Grail acquisition before the European Commission finished its inquiry into the tie-up. The penalty is the maximum amount the regulator can impose on a company for breaching European merger rules.

Amplified Sciences secures $400,000 grant to develop pancreatic cancer diagnostic test - Vimarsana News

Amplified Sciences secures $400,000 grant to develop pancreatic cancer diagnostic test

Health care providers and their patients could know with greater confidence whether pancreatic cysts are benign or potentially malignant, and if surgery is required to remove them, by using a new diagnostic test currently in development.